Han Xue-yao, Ji Li-nong, Zhou Xiang-hai
Department of Endocrinology, Peking University People's Hospital, Beijing 100044, China.
Beijing Da Xue Xue Bao Yi Xue Ban. 2005 Apr 18;37(2):159-62.
To explore the pathophysiologic and clinical features and investigate the roles of insulin resistance and insulin secretion in the pathogenesis of type 2 diabetes mellitus.
A total of 888 first-degree relatives without glucose intolerance history underwent an oral glucose test (OGTT) and their level of HbA1c, insulin concentration and lipid levels were determined. The homeostasis model assessment was used to estimate insulin resistance (HOMA(IR)) and beta-cell function (HOMA-beta). The ratio of incremental glucose (DeltaG30) and insulin (DeltaI30) response was used to evaluate the early insulin secretion. DeltaI30/DeltaG30/HOMAIR was used to evaluate the glucose disposition index (DI).
In the subjects, 167 were diagnosed with diabetes, 180 with impaired glucose tolerance or/and impaired fasting glucose (impared glucose regulation), 457 with normal glucose tolerance and normal HbA1c, and 84 with normal glucose tolerance and high HbA1c. From normal glucose tolerance through impared glucose regulation to diabetes mellitus, the HOMA(IR), body mass index (BMI), waist/hip ratio (WHR) and serum triglyceride (TG) progressively increased, HOMA-beta cell, DeltaI30/DeltaG30, DI and high density liproprotein (HDL) progressively decreased. Subjects with normal glucose tolerance were divided into three tertile subgroups (1/3, 2/3 and 3/3 groups) with different area under the curve of OGTT glucose, after being adjusted by sex, age, BMI, the 3/3 group was found having higher HOMA(IR), and lower HOMA-beta, DeltaI30/DeltaG30/, and DI than the 1/3 group.
Both insulin resistance and impaired beta cell function are important pathophysiologic changes contributing to the onset and development of type 2 diabetes. These changes and lipid profile have occurred before a patient is diagnosed with abnormal glucose tolerance.
探讨2型糖尿病发病机制中的病理生理及临床特征,并研究胰岛素抵抗和胰岛素分泌在其发病过程中的作用。
对888名无糖耐量异常病史的一级亲属进行口服葡萄糖耐量试验(OGTT),并测定其糖化血红蛋白(HbA1c)水平、胰岛素浓度和血脂水平。采用稳态模型评估法估算胰岛素抵抗(HOMA-IR)和β细胞功能(HOMA-β)。用葡萄糖增加值(ΔG30)与胰岛素增加值(ΔI30)的比值评估早期胰岛素分泌。用ΔI30/ΔG30/HOMA-IR评估葡萄糖处置指数(DI)。
在这些受试者中,167人被诊断为糖尿病,180人患有糖耐量受损或/和空腹血糖受损(糖调节受损),457人糖耐量正常且HbA1c正常,84人糖耐量正常但HbA1c升高。从糖耐量正常到糖调节受损再到糖尿病,HOMA-IR、体重指数(BMI)、腰臀比(WHR)和血清甘油三酯(TG)逐渐升高,HOMA-β细胞、ΔI30/ΔG30、DI和高密度脂蛋白(HDL)逐渐降低。将糖耐量正常的受试者按OGTT葡萄糖曲线下面积分为三个三分位数亚组(1/3、2/3和3/3组),经性别、年龄、BMI校正后,发现3/3组的HOMA-IR高于1/3组,而HOMA-β、ΔI30/ΔG30/和DI低于1/3组。
胰岛素抵抗和β细胞功能受损都是导致2型糖尿病发生和发展的重要病理生理变化。这些变化及血脂异常在患者被诊断为糖耐量异常之前就已出现。